Renejix – Small Molecule CDMO (USA)
| Renejix’s Prime Pharma Solution offers the fastest route from clinical to commercial manufacturing. Through a proactive strategy, it evaluates production aspects in the early developmental stages. This approach aids in risk reduction by concurrently tackling potential obstacles, thus guaranteeing resilient processes spanning from clinical phases to product launch. |
Abstract: This case study provides a deep dive into Renejix’s achievement in developing a multi-API (Active Pharmaceutical Ingredient) fixed-dose combination oral drug,…
Maintaining high standards of quality and safety is essential in pharmaceutical manufacturing. Two fundamental concepts that guide this industry are Good Manufacturing…
Please check out the below links to access our list of equipments available at the respective locations1. Hauppauge, New York2. Islip, New…
Streamline your clinical trials with ease using our top-tier blinding services. Effortlessly manage clinical supplies, minimize errors, and guarantee confidentiality. Boost your…
A newly formed pharmaceutical company was creating a novel cardiometabolic drug, a new small molecule, that was in Phase 2a testing in…
